These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1575821)

  • 1. Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins.
    Bhatnagar D; Durrington PN; Mackness MI; Arrol S; Winocour PH; Prais H
    Atherosclerosis; 1992 Jan; 92(1):49-57. PubMed ID: 1575821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the gemfibrozil-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins.
    Ponsin G; Girardot G; Berthezene F
    Biochem Med Metab Biol; 1994 Jun; 52(1):58-64. PubMed ID: 7917468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
    Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM
    Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients.
    Dachet C; Cavallero E; Martin C; Girardot G; Jacotot B
    Atherosclerosis; 1995 Feb; 113(1):1-9. PubMed ID: 7755644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
    Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
    Eisenberg S; Gavish D; Oschry Y; Fainaru M; Deckelbaum RJ
    J Clin Invest; 1984 Aug; 74(2):470-82. PubMed ID: 6378975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.
    Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Dean J; Boulton AJ
    Diabetes; 1995 Apr; 44(4):460-5. PubMed ID: 7698516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
    Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
    Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl ester transfer activity. Localization and role in distribution of cholesteryl ester among lipoproteins in man.
    Groener JE; Van Rozen AJ; Erkelens DW
    Atherosclerosis; 1984 Mar; 50(3):261-71. PubMed ID: 6712775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein?
    Oschry Y; Olivecrona T; Deckelbaum RJ; Eisenberg S
    J Lipid Res; 1985 Feb; 26(2):158-67. PubMed ID: 3989374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls.
    Lottenberg SA; Lottenberg AM; Nunes VS; McPherson R; Quintão EC
    Atherosclerosis; 1996 Nov; 127(1):81-90. PubMed ID: 9006808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.